CD82 and leukemia: Taken together, our results suggest that CD82 regulates the expression of EZH2 in leukemia cells via p38 MAPK signaling, resulting in both H3K27me3 and methylation in the PTEN promoter region, thereby resulting in repression of PTEN transcription.